ISCBacademy: Gemma Turon on open source AI/ML for (antimicrobial) drug discovery

Gemma Turon, PhD (CEO and co-founder at Ersilia Open Source Initiative) will present on March 5

BOSC and the OBF will host an ISCBacademy webinar on March 5, 2024, at 8am PST (16:00 UTC). Gemma Turon (see bio below) will speak about “Ersilia, open source AI/ML for (antimicrobial) drug discovery”.

Abstract

The Ersilia Open-Source Initiative is a non-profit organisation whose mission is to equip laboratories, clinics and universities in lower and middle income countries (LMICs) with artificial intelligence (AI) tools for infectious disease research. The goal of our mission is to strengthen the research capacity in those countries where these diseases are predominant, supporting the in-country drug discovery pipelines for neglected and infectious diseases. Since its foundation in 2020, we have collaborated with several institutions in the Global South as well as international consortiums. In this introductory talk we will present our computational approach and infrastructure, including the Ersilia Model Hub, a unified platform offering ready- to-use AI models to researchers worldwide, and how we have used it across multiple projects, offering a perspective on how AI/ML can transform drug discovery and contribute towards a more egalitarian world of biomedical research.

[Read More]

<strong>Spotlight on diversity: Jenea Adams</strong>

Diversity, inclusion and accessibility (also known as Diversity, Equity and Inclusion, DEI) are a major part of BOSC’s mission and core values, and we pursue these goals in multiple ways. BOSC 2022, for example, included a panel on Building and Sustaining Inclusive Open Science Communities, with panelists who not only were experts on the topic but also themselves belong to various groups that are typically underrepresented in our community. And with generous support from our sponsors, each year we provide free registration to 10-20 BOSC participants as part of the OBF Event Fellowship program), which aims to increase diverse participation at events related to open source bioinformatics and open science.

[Read More]